Project Grant R56EB034702
Award Date
9/19/23
Completion Date
9/18/24
Dollars Obligated
$499K
Federal Agency
National Institute of Biomedical Imaging and Bioenginering
Federal Grant Program
93.286
Assistance Type
Project Grant
Place of Performance
Boston, MA 02115, USA
Similar Awards
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to develop a novel pressure-sensitive bioadhesive (PSB) system for minimally invasive surgery (MIS). The $625,168 award, effective from March 2025 through November 2028, will support the fabrication of PSBs with tunable viscoelastic and adhesive properties for wet tissue...
This $1,736,793 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) aims to develop a novel 3D printing technology called "3D Printing of Air" (3DAIRP). The 3DAIRP process can rapidly generate stable vascular networks within engineered tissues and organs, overcoming limitations of current sacrificial ink approaches. The...
This federal Project Grant award of $169,702 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286) will support the development and validation of a novel multiscale computational model to design and fabricate complex, spatially patterned tissue assembloids for biomanufacturing applications. The key objectives are to: 1) Develop a multiscale...
This federal Project Grant award of $460,500 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) is aimed at developing novel bioprinting methodologies for the production of human stem cell-based organoids. The key objectives are to: 1) Create a customized bioink formulation using proteins, polysaccharides, and functionalized nanoparticles to foster the...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $389,751 Project Grant under CFDA 93.286, "Discovery and Applied Research for Technological Innovations to Improve Human Health," to the Regents of the University of Minnesota, Office of Sponsored Projects Administration. This 2-year grant aims to develop a low-cost, compact holographic imaging-based microfluidic cell sorting system using 3D printing. The research will explore the use of 3D holographic...
This NSF Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award to President and Fellows of Harvard College (Harvard University) provides $550,000 in funding from August 1, 2024 to July 31, 2026 to develop a minimally-invasive, catheter-based additive manufacturing platform capable of creating customized medical implants directly inside the human body. The project aims to transform the field of medical implants by enabling on-demand fabrication of personalized 3D-printed...
The Department of Health and Human Services' National Institutes of Health Office of the Director awarded the University of Texas at Austin a $2,708,214 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to develop a novel semi-autonomous surgeon-in-the-loop robotic bioprinting system. The system aims to enable in situ robotic bioprinting of human tissues and organs to simultaneously restore functional and cosmetic capabilities lost due to volumetric muscle loss injuries. A...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Phase I Small Business Innovation Research (SBIR) grant, awarded to Tissueform, Inc., a for-profit woman-owned small business in Boulder, Colorado, aims to develop a library of human-based bioinks for 3D bioprinting applications. The $274,822 award, with a performance period from September 2024 to August 2025, will focus on creating granulated bioinks for tissues such as cartilage, bone, skin, liver,...
This $1,016,449.00 Project Grant award was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports single-cell studies of immune-mediated injury and immunoregulation in human vascular composite allograft (VCA) rejection, with a performance period from August 1, 2024 to July 31, 2027. The award was granted to Brigham & Women's Hospital Inc., a prominent academic medical center and research institution in...
This $1,683,194 federal Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports Brigham & Women's Hospital Inc., a Harvard-affiliated academic medical center, in conducting research on the role of the glycome in identifying biomarkers and understanding the molecular pathogenesis of tuberous sclerosis complex (TSC). The 3-year grant, running from August 2025 to July 2028, will fund advanced...